Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN002673 | AC(8:1) [M+H]+ | 286.2019 | 27 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_Sphingosine(d17:1) iSTD [M+H]+ | 286.274473 | 58.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(10:1) [M+H]+ | 314.2333121 | 3 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(10:0) [M+H]+ | 316.2454366 | 32.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(11:1) [M+H]+ | 328.248 | 31.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_CUDA iSTD [M+H]+ | 341.2799548 | 44.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(12:1) [M+H]+ | 342.2642 | 36 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_MG(17:0/0:0/0:0) iSTD [M+H]+ | 345.3001669 | 181.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(13:1) [M+H]+ | 356.2796 | 40.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_MG (17:0/0:0/0:0) iSTD [M+NH4]+ | 362.3260178 | 181.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_MG(17:0/0:0/0:0) iSTD [M+Na]+ | 367.2817723 | 181.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(14:2) [M+H]+ | 368.2798 | 39.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cholesterol [M+H-H2O]+ | 369.3518472 | 290.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(14:1) [M+H]+ | 370.2915954 | 46.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(14:0) [M+H]+ | 372.3100795 | 59.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_Cholesterol d7 iSTD [M-H2O+H]+ | 376.3960224 | 286.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(16:1) [M+H]+ | 398.3244177 | 66.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(16:0) [M+H]+ | 400.3421729 | 89.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_DG(18:1/2:0/0:0) iSTD [M+NH4]+ | 416.33778 | 190.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_DG(18:1/2:0/0:0) iSTD [M+Na]+ | 421.2930973 | 189.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(18:2) [M+H]+ | 424.341107 | 75.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(18:1) B [M+H]+ | 426.3575764 | 102.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(18:1) A [M+H]+ | 426.3578 | 98.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(18:0) [M+H]+ | 428.3719092 | 134.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_DG(18:1/2:0/0:0) iSTD [M+K]+ | 437.2662315 | 190.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPE(16:0) [M+H]+ | 454.2946157 | 85.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_LPE(17:1) iSTD [M+H]+ | 466.2943109 | 76.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(14:0) [M+H]+ | 468.3091069 | 55.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_DG(12:0/12:0/0:0) iSTD [M+NH4]+ | 474.4153546 | 255.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPE(18:2) [M+H]+ | 478.2946127 | 71.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_DG(12:0/12:0/0:0) iSTD [M+Na]+ | 479.370944 | 255.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(p-16:0)/LPC(o-16:1) [M+H]+ | 480.3427534 | 95.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPE(18:0) [M+H]+ | 482.3248335 | 133.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(15:0) [M+H]+ | 482.3264277 | 67.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(o-16:0) [M+H]+ | 482.3609269 | 99 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(16:1) [M+H]+ | 494.3240866 | 61.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_DG(12:0/12:0/0:0) iSTD [M+K]+ | 495.347276 | 255.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(16:0e)/PC(14:0e/2:0) [M+H]+ | 496.3418376 | 76.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(16:0) [M+H]+ | 496.3427569 | 83.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(17:1) [M+H]+ | 508.3382928 | 75 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(p-18:0)/LPC(o-18:1) [M+H]+ | 508.3763 | 108 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_LPC(17:0) iSTD [M+H]+ | 510.3571824 | 108 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(24:0) [M+H]+ | 512.4659662 | 24 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(18:2e)/PC(16:2e/2:0) [M+H]+ | 520.3404607 | 65.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(18:2) [M+H]+ | 520.3424146 | 70.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(18:1e)/PC(16:1e/2:0) [M+H]+ | 522.3552278 | 84.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(18:1) [M+H]+ | 522.3579067 | 96.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(18:0e)/PC(16:0e/2:0) [M+H]+ | 524.3719327 | 117.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(18:0) [M+H]+ | 524.3729689 | 128.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPE(20:6) [M+H]+ | 526.2941414 | 69 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_Cer(d18:1/17:0) iSTD [M+H-H2O]+ | 534.5247084 | 357 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d34:1) [M+H]+ | 538.5200163 | 336 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | AC(26:0) [M+H]+ | 540.4969122 | 274.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(20:5) [M+H]+ | 542.3259814 | 54 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(20:4) A [M+H]+ | 544.3400121 | 64.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(20:4) B [M+H]+ | 544.3415181 | 70.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(20:3) [M+H]+ | 546.3547767 | 81.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(20:2) [M+H]+ | 548.371451 | 103.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d36:1) [M+H-H2O]+ | 548.5404 | 377.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(20:1) [M+H]+ | 550.3864068 | 137.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(20:0) [M+H]+ | 552.4029679 | 181.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_Cer(d18:1/17:0) iSTD [M+H]+ | 552.5356877 | 357 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d36:1) [M+H]+ | 566.5508 | 377.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(22:6) [M+H]+ | 568.3395125 | 64.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(22:5) [M+H]+ | 570.3565495 | 73.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC(22:4) [M+H]+ | 572.3725107 | 94.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_Cer(d18:1/17:0) iSTD [M+Na]+ | 574.5174632 | 357.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DAG 32:2; DAG 14:0-18:2; [M+NH4]+ | 582.5091 | 342 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DAG 32:1; DAG 16:0-16:1; [M+NH4]+ | 584.525 | 374.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DAG 32:0; DAG 16:0-16:0; [M+NH4]+ | 586.5408 | 410.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d36:1) [M+Na]+ | 588.5306023 | 378 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d38:1) [M+H]+ | 594.5828 | 419.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d40:1) [M+H-H2O]+ | 604.6021129 | 459.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | LPC24:0 [M+H]+ | 608.4664331 | 243.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:3) [M+NH4]+ | 608.5249 | 346.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:2) [M+NH4]+ | 610.5397457 | 382.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:1) [M+NH4]+ | 612.5556725 | 414.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:3) [M+Na]+ | 613.4808122 | 346.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:2) [M+Na]+ | 615.4960248 | 382.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d38:1) [M+Na]+ | 616.5624827 | 42 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:1) [M+Na]+ | 617.5110913 | 414.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d41:1) [M+H-H2O]+ | 618.61566 | 478.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d40:1) [M+H]+ | 622.6116165 | 459.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:3) [M+K]+ | 629.4543 | 346.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:2) A [M+H-H2O]+ | 630.6174764 | 457.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:2) B [M+H-H2O]+ | 630.618366 | 465 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:2) [M+K]+ | 631.4733502 | 382.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:5) [M+NH4]+ | 632.5253 | 327 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:1) [M+H-H2O]+ | 632.6333945 | 497.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(34:1) [M+K]+ | 633.4841607 | 414 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:4) A [M+NH4]+ | 634.5402227 | 354.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_PC(12:0/13:0) iSTD [M+H]+ | 636.4596684 | 21 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:3) [M+NH4]+ | 636.555352 | 386.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d41:1) [M+H]+ | 636.6301206 | 478.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DAG 36:2; DAG 18:1-18:1; [M+NH4]+ | 638.5727 | 382.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:2) [M+NH4]+ | 638.5730888 | 418.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:4) A [M+Na]+ | 639.4958842 | 354 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:1) [M+NH4]+ | 640.5878 | 454.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DAG 36:1; DAG 18:0-18:1; [M+NH4]+ | 640.5881 | 414.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(16:1) [M+NH4]+ | 640.5976294 | 620.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:3) [M+Na]+ | 641.5111165 | 386.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:2) [M+Na]+ | 643.5269318 | 418.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d40:1) [M+Na]+ | 644.5950116 | 459.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:1) [M+Na]+ | 645.5340748 | 453.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(16:1) [M+Na]+ | 645.5559038 | 619.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d30:1) [M+H]+ | 647.5125643 | 217.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:2) A [M+H]+ | 648.6271611 | 457.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:2) B [M+H]+ | 648.6278028 | 465 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:1) [M+H]+ | 650.6436261 | 497.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:4) A [M+K]+ | 655.4703 | 354 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:3) [M+K]+ | 657.4853136 | 386.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(38:6) [M+NH4]+ | 658.5406 | 345.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d41:1) [M+Na]+ | 658.6089665 | 478.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(36:2) [M+K]+ | 659.4993625 | 418.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(38:5) [M+NH4]+ | 660.5560473 | 376.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(38:6) [M+Na]+ | 663.492965 | 345.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:3) [M+NH4]+ | 664.5997044 | 6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(38:5) [M+Na]+ | 665.5118081 | 376.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:2) [M+NH4]+ | 666.6198196 | 624.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:1) [M+NH4]+ | 668.6356529 | 652.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:3) [M+Na]+ | 669.5574593 | 599.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:2) B [M+Na]+ | 670.6097881 | 465 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:2) A [M+Na]+ | 670.6103729 | 457.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:2) [M+Na]+ | 671.5752459 | 623.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Cer(d42:1) [M+Na]+ | 672.6256438 | 497.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d32:2) [M+H]+ | 673.5283012 | 222 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:1) [M+Na]+ | 673.5894634 | 653.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d32:1) [M+H]+ | 675.5451429 | 248.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:0) [M+Na]+ | 675.6057 | 680.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d32:0) [M+H]+ | 677.5601748 | 259.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(28:0) [M+H]+ | 678.5079729 | 253.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(38:6) [M+K]+ | 679.4709 | 345.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | DG(38:5) [M+K]+ | 681.486 | 376.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(20:5) [M+NH4]+ | 688.6043037 | 584.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d33:1) [M+H]+ | 689.5607124 | 265.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(20:4) [M+NH4]+ | 690.6198299 | 609.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(30:0e)/PC(14:0e/16:0) [M+H]+ | 692.5594131 | 309.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(20:3) [M+NH4]+ | 692.6308956 | 627.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(20:5) [M+Na]+ | 693.5584792 | 583.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(20:4) [M+Na]+ | 695.5755896 | 610.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(20:2) [M+Na]+ | 699.6047 | 645.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(34:3e)/PE(16:0e/18:3) [M+H]+ | 700.5299102 | 329.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d34:2) [M+H]+ | 701.5632861 | 253.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-34:1)/PE(o-34:2) [M+H]+ | 702.5409277 | 36 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d34:1) [M+H]+ | 703.5792422 | 283.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(30:1)/PC(11:0-19:1) [M+H]+ | 704.5233923 | 259.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d34:0) [M+H]+ | 705.5896888 | 296.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(30:0) [M+H]+ | 706.5411339 | 288.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(40:0) [M+NH4]+ | 712.6457 | 535.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(22:6) [M+NH4]+ | 714.6177648 | 595.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d35:2)/SM(d17:0/18:2) [M+H]+ | 715.5753046 | 271.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(34:2)[M+H]+ | 716.5285909 | 310.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-32:1)/PC(o-32:2) [M+H]+ | 716.5668313 | 289.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(22:5) [M+NH4]+ B | 716.6343 | 610.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(22:5) [M+NH4]+ A | 716.6343 | 619.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_SM(d18:1/17:0) iSTD [M+H]+ | 717.590535 | 302.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(40:0) [M+Na]+ | 717.6009 | 535.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(31:1) [M+H]+ | 718.5399 | 276 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(32:1e)/PC(14:0e/18:1) [M+H]+ | 718.5741292 | 315 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-32:0)/PC(o-32:1) [M+H]+ | 718.5748445 | 342.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(22:6) [M+Na]+ | 719.5747408 | 594.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(31:0) [M+H]+ | 720.5548583 | 306 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_PE(17:0/17:0) iSTD [M+H]+ | 720.5556127 | 375.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(o-32:0) [M+H]+ | 720.5890113 | 348.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(22:2) [M+NH4]+ | 722.6828012 | 681 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-36:4)/PE(o-36:5) [M+H]+ | 724.5265794 | 322.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_CE(22:1) iSTD [M+NH4]+ | 724.6985132 | 703.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(36:4e)/PE(16:0e/20:4) [M+H]+ | 726.5411215 | 338.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d36:3) [M+H]+ | 727.575233 | 263.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(22:2) [M+Na]+ | 727.6364528 | 681 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(32:3) [M+H]+ | 728.5219768 | 288.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-36:2)/PE(o-36:3) [M+H]+ | 728.5588852 | 369 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d36:2) [M+H]+ | 729.5922901 | 289.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_CE(22:1) iSTD [M+Na]+ | 729.6534767 | 703.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(32:2) [M+H]+ | 730.538647 | 266.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(32:2)/PC(16:1-16:1) [M+H]+ | 730.5479248 | 282 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-36:1)/PE(o-36:2) [M+H]+ | 730.5759024 | 400.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d36:1) [M+H]+ | 731.6090618 | 321.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(32:1) [M+H]+ | 732.5559962 | 292.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d36:0) [M+H]+ | 733.6206874 | 336 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(32:0) [M+H]+ | 734.57258 | 325.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(42:2) [M+NH4]+ | 736.6456 | 508.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:5e)/PC(16:0e/18:5) [M+H]+ | 738.5501643 | 289.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(42:1)/TAG(12:0-14:0-16:1) [M+NH4]+ | 738.6608 | 537.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(36:4)[M+H]+ | 740.527425 | 305.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:4e)/PC(14:0e/20:4) [M+H]+ | 740.5549372 | 291 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(42:0) [M+NH4]+ | 740.6749169 | 567 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(42:2) [M+Na]+ | 741.6006 | 509.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:3e)/PC(14:0e/20:3) [M+H]+ | 742.5714911 | 297 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-34:2)/PC(o-34:3) [M+H]+ | 742.5758621 | 317.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(33:2) [M+H]+ | 744.5549621 | 283.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-34:1)/PC(o-34:2) [M+H]+ | 744.5917325 | 322.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d37:1) [M+H]+ | 745.6206658 | 342 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(42:0) [M+Na]+ | 745.6321 | 567 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(33:1) [M+H]+ | 746.5684528 | 311.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(36:1)[M+H]+ | 746.5725448 | 380.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:1e)/PC(14:0e/20:1) [M+H]+ | 746.6068437 | 351.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(33:0) [M+H]+ | 748.5857189 | 337.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(o-34:0) [M+H]+ | 748.619574 | 388.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-38:5)/PE(o-38:6) [M+H]+ | 750.5460759 | 326.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:4) [M+H]+ | 754.5370894 | 261.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:4)/PC(17:2-17:2) [M+H]+ | 754.5405298 | 253.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:3) C [M+H]+ | 756.5530965 | 282 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:3) B [M+H]+ | 756.5543869 | 277.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:3) A [M+H]+ | 756.5554835 | 271.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(35:3e)/PC(18:3e/17:0) [M+H]+ | 756.5935789 | 336 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(42:2) [M+K]+ | 757.5745 | 509.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d38:2) [M+H]+ | 757.6218113 | 328.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:2) [M+H]+ | 758.5754149 | 301.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(42:1) [M+K]+ | 759.59 | 537 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d38:1) [M+H]+ | 759.6386695 | 362.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:1) [M+H]+ | 760.590638 | 33 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d38:0) [M+H]+ | 761.648087 | 376.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(34:0) [M+H]+ | 762.6028627 | 364.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(38:6)[M+H]+ | 764.5250532 | 295.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-36:5)/PC(o-36:6) [M+H]+ | 764.5596318 | 288 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:2) [M+NH4]+ | 764.6791719 | 541.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:5e)/PC(16:0e/20:5) [M+H]+ | 766.5734615 | 291.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-36:4)/PC(o-36:5) [M+H]+ | 766.5767727 | 310.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:1) [M+NH4]+ | 766.692041 | 569.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(35:4) [M+H]+ | 768.5541537 | 278.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(38:4)[M+H]+ | 768.555267 | 343.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PG(34:0)/PG(17:0-17:0) [M+NH4]+ | 768.5794945 | 334.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-36:3)/PC (o-36:4) [M+H]+ | 768.592809 | 317.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:0) [M+NH4]+ | 768.7056093 | 597 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:2) [M+Na]+ | 769.6317 | 541.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(35:3) [M+H]+ | 770.5709133 | 289.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-36:2)/PC(o-36:3) [M+H]+ | 770.6027527 | 356.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:3e)/PC(14:1e/22:2) [M+H]+ | 770.6051242 | 326.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:3e)/PC(14:0e/22:3) [M+H]+ | 770.6061652 | 333 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:1) [M+Na]+ | 771.6463076 | 568.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(35:2) A [M+H]+ | 772.5852805 | 314.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(35:2) B [M+H]+ | 772.5862975 | 319.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-36:1)/PC(o-36:2) B [M+H]+ | 772.6205545 | 387 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-36:1)/PC(o-36:2) A [M+H]+ | 772.6215365 | 362.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d39:1) [M+H]+ | 773.6533846 | 382.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:0) [M+Na]+ | 773.6653339 | 596.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(35:1) [M+H]+ | 774.5996496 | 349.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:1e)/PC(14:0e/22:1) [M+H]+ | 774.6369372 | 393 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:6) [M+H]+ | 778.5388838 | 253.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-40:5)/PE(o-40:6) [M+H]+ | 778.574341 | 363 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:5)A [M+H]+ | 780.5550509 | 256.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:5) D [M+H]+ | 780.5561638 | 273 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:5) C [M+H]+ | 780.5584993 | 266.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-40:4)/PE(o-40:5)B [M+H]+ | 780.5907703 | 402 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PE(p-40:4)/PE(o-40:5)A [M+H]+ | 780.5935827 | 39 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:4) B [M+H]+ | 782.570296 | 288 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:4) A [M+H]+ | 782.5719078 | 278.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:4) C [M+H]+ | 782.5751565 | 295.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(45:0)/TAG(14:0-15:0-16:0) [M+NH4]+ | 782.7210234 | 610.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:3) A [M+H]+ | 784.5872578 | 305.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:3) B [M+H]+ | 784.5879383 | 310.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d40:1) [M+H]+ | 784.667038 | 419.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:2) [M+K]+ | 785.6055 | 541.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d40:2) B [M+H]+ | 785.6557892 | 368.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:2) [M+H]+ | 786.6056949 | 339 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:1) [M+K]+ | 787.6219 | 568.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d40:1) [M+H]+ | 787.6711631 | 402 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(36:1) [M+H]+ | 788.6194186 | 368.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:4) A [M+NH4]+ | 788.6763 | 518.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(44:0) [M+K]+ | 789.6371 | 595.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d40:0) [M+H]+ | 789.6838736 | 417 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:7e)/PC(16:1e/22:6) [M+H]+ | 790.5741405 | 289.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-38:6)/PC(o-38:7) [M+H]+ | 790.5768601 | 300.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:3) A [M+NH4]+ | 790.6903237 | 544.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(37:6) [M+H]+ | 792.5520816 | 27 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:6e)/PC(16:1e/22:5) [M+H]+ | 792.5863332 | 291 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:6e)/PC(16:0e/22:6) [M+H]+ | 792.588369 | 325.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-38:5)/PC(o-38:6) A [M+H]+ | 792.5909122 | 306.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-38:5)/PC(o-38:6) B [M+H]+ | 792.5918762 | 314.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:2) [M+NH4]+ | 792.7084224 | 572.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:4) A [M+Na]+ | 793.6315 | 517.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(37:5) [M+H]+ | 794.5746263 | 290.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-38:4)/PC(o-38:5) B [M+H]+ | 794.6053595 | 349.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-38:4)/PC(o-38:5) A [M+H]+ | 794.6067226 | 320.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:1) [M+NH4]+ | 794.7299778 | 598.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:3) A [M+Na]+ | 795.6422349 | 544.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(37:4) [M+H]+ | 796.5866705 | 309 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-38:3)/PC(o-38:4) B [M+H]+ | 796.6233309 | 355.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:0) [M+NH4]+ | 796.7394971 | 624 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:2) [M+Na]+ | 797.6638145 | 572.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(37:3)/PC(17:0-20:3) [M+H]+ | 798.5995241 | 329.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(37:3) [M+H]+ | 798.6011847 | 324 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-38:2)/PC(o-38:3) [M+H]+ | 798.6385392 | 372 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d41:2) A [M+H]+ | 799.6683849 | 381.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d41:2)B [M+H]+ | 799.6706132 | 388.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:1) [M+Na]+ | 799.6810401 | 597.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(37:2) [M+H]+ | 800.6155639 | 358.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:2e)/PC(14:0e/24:2) [M+H]+ | 800.653769 | 401.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d41:1) [M+H]+ | 801.6844197 | 422.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:0) [M+Na]+ | 801.6935366 | 623.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:7) [M+H]+ | 804.5539 | 258.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:6) C [M+H]+ | 806.5689385 | 311.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:6) B [M+H]+ | 806.5716608 | 288 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:6) A [M+H]+ | 806.5718497 | 273.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d40:1) [M+Na]+ | 806.646799 | 419.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(47:2)/TAG(14:0-15:0-18:2) [M+NH4]+ | 806.7201722 | 586.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:5) B [M+H]+ | 808.5847015 | 310.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:5) A [M+H]+ | 808.58674 | 298.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(47:1)/TAG(14:0-15:0-18:1) [M+NH4]+ | 808.737505 | 611.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(47:1) [M+NH4]+ | 808.7391 | 612.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:4) A [M+H]+ | 810.6006273 | 315 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:4) B [M+H]+ | 810.6020946 | 322.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:4) C [M+H]+ | 810.6057437 | 333 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d42:2) [M+H]+ | 810.6804439 | 418.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(47:0)/TAG(14:0-16:0-17:0) [M+NH4]+ | 810.7533679 | 637.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:3) A [M+K]+ | 811.6212 | 544.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d42:3) [M+H]+ | 811.6685186 | 367.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:3)/PC(18:0-20:3) [M+H]+ | 812.6165569 | 361.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:3) [M+H]+ | 812.6170795 | 349.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d42:1) [M+H]+ | 812.6969608 | 458.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:2) [M+K]+ | 813.6375 | 572.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d42:2) [M+H]+ | 813.6867625 | 401.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(47:1) [M+Na]+ | 813.6954884 | 612.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:9e)/PC(22:4e/18:5) [M+H]+ | 814.5746868 | 314.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(38:2) [M+H]+ | 814.634286 | 373.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:5) [M+NH4]+ | 814.6913 | 524.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(46:1) [M+K]+ | 815.6532 | 597.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d42:1) [M+H]+ | 815.7030295 | 442.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:8e)/PC(22:3e/18:5) [M+H]+ | 816.5878121 | 320.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-40:7)/PC(o-40:8) [M+H]+ | 816.5905432 | 304.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:4) B [M+NH4]+ | 816.7068691 | 550.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-40:6)/PC(o-40:7) A [M+H]+ | 818.5992609 | 310.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-40:6)/PC(o-40:7) B [M+H]+ | 818.606 | 337.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:3) [M+NH4]+ | 818.7262446 | 574.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:5) [M+Na]+ | 819.6475 | 524.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(39:6) [M+H]+ | 820.5803186 | 298.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(39:6)/PC(17:1-22:5) [M+H]+ | 820.5831961 | 304.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:6e)/PC(16:2e/24:4) [M+H]+ | 820.6195036 | 324.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-40:5)/PC(o-40:6) [M+H]+ | 820.6203827 | 344.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:2) [M+NH4]+ | 820.7411355 | 601.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:4) B [M+Na]+ | 821.663754 | 550.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(39:5)/PC(13:1-26:4) [M+H]+ | 822.5977954 | 316.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-40:4)/PC(o-40:5) [M+H]+ | 822.6348921 | 357 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:1) [M+NH4]+ | 822.7570021 | 625.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:3) [M+Na]+ | 823.6815965 | 574.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:4e)/PC(16:2e/24:2) [M+H]+ | 824.6488 | 368.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-40:3)/PC(o-40:4) [M+H]+ | 824.6537583 | 395.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:2) [M+Na]+ | 825.6943614 | 6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:3e)/PC(14:1e/26:2) [M+H]+ | 826.667318 | 400.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d43:2) [M+H]+ | 827.6982732 | 414 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:1) [M+Na]+ | 827.7112653 | 624.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d43:1) [M+H]+ | 829.7144329 | 454.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d43:1)/SM(d14:1/29:0) [M+H]+ | 829.7172429 | 461.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:8) [M+H]+ | 830.5703064 | 266.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:7) A [M+H]+ | 832.5849145 | 282 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:7) B [M+H]+ | 832.58684 | 290.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d42:2) [M+Na]+ | 832.6633445 | 418.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:3) [M+NH4]+ | 832.7414583 | 589.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:6)B [M+H]+ | 834.601463 | 322.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:6) A [M+H]+ | 834.6020892 | 305.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d42:1) [M+Na]+ | 834.6759087 | 458.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:2) [M+NH4]+ | 834.7534858 | 612 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:5) B [M+H]+ | 836.6171766 | 348.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:5) A [M+H]+ | 836.6180555 | 334.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:1) [M+NH4]+ | 836.7724106 | 637.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:4) A [M+K]+ | 837.637 | 549.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:3) [M+Na]+ | 837.6961216 | 589.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:4) [M+H]+ | 838.6321764 | 361.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(40:4)/PC(20:2-20:2) [M+H]+ | 838.6334946 | 371.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:0) [M+NH4]+ | 838.7840186 | 657 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:3) [M+K]+ | 839.657777 | 574.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:2) [M+Na]+ | 839.7096001 | 613.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:2) [M+K]+ | 841.6723543 | 6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | SM(d44:2) [M+H]+ | 841.7156493 | 439.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:1) [M+Na]+ | 841.7276053 | 638.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:5) [M+NH4]+ | 842.7233555 | 556.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(48:1) [M+K]+ | 843.6861264 | 624.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:4)/TAG(14:1-18:1-18:2) [M+NH4]+ | 844.7393 | 550.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:4) [M+NH4]+ | 844.7416963 | 579.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:3) A [M+NH4]+ | 846.7566907 | 603.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:5) [M+Na]+ | 847.6795326 | 556.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-42:5)/PC(o-42:6) B [M+H]+ | 848.6509014 | 388.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-42:5)/PC(o-42:6) A [M+H]+ | 848.6528626 | 362.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:2) [M+NH4]+ | 848.7734389 | 627 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:4) [M+Na]+ | 849.6963643 | 579.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:5e)/PC(18:5e/24:0) [M+H]+ | 850.6659666 | 400.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-42:4)/PC(o-42:5) [M+H]+ | 850.6686791 | 394.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:3) A [M+Na]+ | 851.7119738 | 603 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:4e)/PC(16:2e/26:2) [M+H]+ | 852.6818687 | 405.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-42:3)/PC(o-42:4) [M+H]+ | 852.6834393 | 434.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:0) [M+NH4]+ | 852.8013757 | 673.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:2) [M+Na]+ | 853.7282239 | 626.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:10) [M+H]+ | 854.5661543 | 259.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:3e)/PC(16:1e/26:2) [M+H]+ | 854.7002476 | 439.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:5) [M+NH4]+ | 856.7394 | 571.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(49:1) [M+K]+ | 857.7006 | 638.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:0) [M+Na]+ | 857.756569 | 673.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:8)/PC(20:4-22:4) [M+H]+ | 858.5999801 | 291.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:4) [M+NH4]+ | 858.7550543 | 594 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:7)/PC(16:3-26:4) [M+H]+ | 860.6164048 | 324.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:3) [M+NH4]+ | 860.7702306 | 617.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:5) [M+Na]+ | 861.6945 | 571.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d34:1) [M+H]+ | 862.6266454 | 287.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:6) [M+H]+ | 862.6302361 | 347.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:2) [M+NH4]+ | 862.7875001 | 639 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:5) [M+K]+ | 863.6532 | 556.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:4) [M+Na]+ | 863.7086982 | 594 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(42:5) [M+H]+ | 864.6479144 | 364.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:1) [M+NH4]+ | 864.8025891 | 660.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:4) [M+K]+ | 865.6715747 | 579 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:3) [M+Na]+ | 865.7261509 | 617.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:0)/TAG(16:0-17:0-18:0) [M+NH4]+ | 866.8172 | 682.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:3) A [M+K]+ | 867.6847895 | 603 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:2) [M+Na]+ | 867.7433519 | 639 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:6)/TAG(16:1-18:2-18:3) [M+NH4]+ | 868.737682 | 560.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:6) [M+NH4]+ | 868.7385986 | 568.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:2) [M+K]+ | 869.6983693 | 626.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_TAG d5(17:0/17:1/17:0) iSTD [M+NH4]+ | 869.8368796 | 661.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:5) [M+NH4]+ | 870.756878 | 585.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:1) [M+K]+ | 871.7200907 | 649.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:4)/TAG(16:1-18:1-18:2) [M+NH4]+ | 872.7595195 | 580.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:4)/TAG(16:0-18:2-18:2) [M+NH4]+ | 872.770523 | 621 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:4) [M+NH4]+ | 872.7743089 | 607.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:6) [M+Na]+ | 873.6956067 | 568.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(50:0) [M+K]+ | 873.7336 | 672.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:3) [M+NH4]+ | 874.7908318 | 63 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_TAG d5(17:0/17:1/17:0) iSTD [M+Na]+ | 874.7922392 | 661.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:5) [M+Na]+ | 875.7120944 | 585 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(44:6e)/PC(18:2e/26:4) [M+H]+ | 876.6833947 | 400.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-44:5)/PC(o-44:6) | 876.6858569 | 426 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:4) [M+Na]+ | 877.7292561 | 607.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(p-44:4)/PC(o-44:5) [M+H]+ | 878.6999524 | 432.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:1) [M+NH4]+ | 878.8187338 | 674.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:3) [M+Na]+ | 879.7440473 | 629.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(44:4e)/PC(18:2e/26:2) [M+H]+ | 880.7141085 | 448.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:0) [M+NH4]+ | 880.8295506 | 696 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:3) [M+K]+ | 881.7091219 | 616.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:2) [M+K]+ | 883.7197829 | 639.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:1) [M+Na]+ | 883.7742405 | 674.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | GlcCer(d34:1) [M+Na]+ | 884.6073973 | 288 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:5) [M+NH4]+ | 884.7690007 | 597 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:5)/TAG(16:0-17:1-20:4) [M+NH4]+ | 884.7720867 | 608.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(51:1) [M+K]+ | 885.7313 | 663 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:0) [M+Na]+ | 885.786409 | 696 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:4) [M+NH4]+ | 886.7863785 | 620.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:3)/TAG(17:0-18:1-18:2) [M+NH4]+ | 888.7913622 | 616.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:3) [M+NH4]+ | 888.8030778 | 640.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:6) [M+K]+ | 889.6687 | 568.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:5) [M+Na]+ | 889.7274835 | 595.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:2) [M+NH4]+ | 890.8151095 | 661.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:5) [M+K]+ | 891.6905683 | 586.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:4) [M+Na]+ | 891.741227 | 619.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:8)/TAG(18:2-18:3-18:3) [M+NH4]+ | 892.7393 | 539.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:1) [M+NH4]+ | 892.8329536 | 684.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:4) [M+K]+ | 893.6986369 | 607.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:3) [M+Na]+ | 893.757892 | 641.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:7)/TAG(16:0-16:1-22:6) [M+NH4]+ | 894.7493475 | 583.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:7) A [M+NH4]+ | 894.7545197 | 563.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:7)/TAG(16:0-18:2-20:5) [M+NH4]+ | 894.7567049 | 578.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:3) [M+K]+ | 895.7152424 | 63 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:2) [M+Na]+ | 895.7763844 | 663 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:6)/TAG(16:0-18:2-20:4) [M+NH4]+ | 896.7693263 | 610.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:6) C [M+NH4]+ | 896.7714498 | 6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:6) A [M+NH4]+ | 896.7745698 | 586.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:2) [M+K]+ | 897.7318416 | 652.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:5) A [M+NH4]+ | 898.7891002 | 609 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:5) B [M+NH4]+ | 898.7908639 | 622.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:7) A [M+Na]+ | 899.7103781 | 563.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(52:1) [M+K]+ | 899.7454608 | 673.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:4)/TAG(18:1-18:1-18:2) [M+NH4]+ | 900.8016017 | 648 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:4) [M+NH4]+ | 900.8053233 | 631.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:6) C [M+Na]+ | 901.7255183 | 598.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:6) A [M+Na]+ | 901.7300246 | 586.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | PC(46:7e)/PC(22:5e/24:2) [M+H]+ | 902.6991846 | 421.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:3) [M+NH4]+ | 902.8211311 | 654 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:5) A [M+Na]+ | 903.7419425 | 610.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:2) [M+NH4]+ | 904.8347459 | 675 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:4) [M+Na]+ | 905.7600401 | 633.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:1) [M+NH4]+ | 906.8470842 | 696 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:3) [M+Na]+ | 907.7741145 | 654.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:3) [M+K]+ | 909.7362843 | 642 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:2) [M+Na]+ | 909.7892196 | 675 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(53:2) [M+K]+ | 911.7482639 | 663.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:1) [M+Na]+ | 911.8014315 | 696 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(55:5)/TAG(17:0-18:1-20:4) [M+NH4]+ | 912.8031899 | 633.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(55:4)/TAG(18:1-18:2-19:1) [M+NH4]+ | 914.8178131 | 643.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:7) A [M+K]+ | 915.6886679 | 562.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(55:3) [M+NH4]+ | 916.836527 | 663 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:6) C [M+K]+ | 917.6993 | 598.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:6) A [M+K]+ | 917.7006507 | 586.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:9) [M+NH4]+ | 918.7532866 | 555 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:5) A [M+K]+ | 919.71565 | 610.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:5) B [M+K]+ | 919.7231391 | 621 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:8) B [M+NH4]+ | 920.7699148 | 588 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:8) A [M+NH4]+ | 920.773765 | 577.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(55:1) [M+NH4]+ | 920.8634 | 705.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:4) [M+K]+ | 921.7341457 | 634.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(55:3) [M+Na]+ | 921.7941153 | 664.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:7) A [M+NH4]+ | 922.7847801 | 6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:7) B [M+NH4]+ | 922.7853503 | 610.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:3) [M+K]+ | 923.746051 | 655.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:6) [M+NH4]+ | 924.806059 | 622.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:8) B [M+Na]+ | 925.729 | 589.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:8) A [M+Na]+ | 925.7297068 | 577.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:2) [M+K]+ | 925.758923 | 675 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:7) A [M+Na]+ | 927.7412636 | 6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(54:1) [M+K]+ | 927.7779 | 695.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:4) [M+NH4]+ | 928.8318004 | 654.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:6) [M+Na]+ | 929.7589897 | 621 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:3) [M+NH4]+ | 930.8468507 | 675 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:5) B [M+Na]+ | 931.7739216 | 640.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:5) C [M+Na]+ | 931.773937 | 646.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:2) [M+NH4]+ | 932.8627408 | 696 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:4) [M+Na]+ | 933.7891684 | 658.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:1) [M+NH4]+ | 934.8783782 | 714 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:3) [M+Na]+ | 935.8045502 | 677.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:2) [M+Na]+ | 937.820239 | 696 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:9) [M+K]+ | 939.6838 | 555 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:1) [M+Na]+ | 939.8328316 | 714 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:8) B [M+K]+ | 941.701 | 589.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:8) A [M+K]+ | 941.7050685 | 577.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:7) A [M+K]+ | 943.7163871 | 599.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:10) [M+NH4]+ | 944.7694029 | 567.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:6) [M+K]+ | 945.7317795 | 620.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:9) [M+NH4]+ | 946.7870258 | 590.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(56:5) C [M+K]+ | 947.7462676 | 645.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:8) [M+NH4]+ | 948.8032149 | 610.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(57:1) [M+NH4]+ | 948.8937 | 72 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:10) [M+Na]+ | 949.725889 | 567.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:7)/TAG(18:1-18:2-22:4) [M+NH4]+ | 950.8147941 | 621.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:7)/TAG(18:1-18:1-22:5) [M+NH4]+ | 950.8181325 | 631.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:9) [M+Na]+ | 951.7421586 | 591 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:6) [M+NH4]+ | 952.8311286 | 642 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:8) [M+Na]+ | 953.7585 | 612.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:6) [M+Na]+ | 957.789616 | 643.2 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:3) [M+NH4]+ | 958.8795 | 699.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:2) [M+NH4]+ | 960.8884229 | 714.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:1) [M+NH4]+ | 962.9081392 | 723 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:3) [M+Na]+ | 963.8394 | 697.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:10) [M+K]+ | 965.6985 | 567 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:2) [M+Na]+ | 965.8476844 | 714 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(58:9) [M+K]+ | 967.7155 | 591 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Lactosylceramide (d18:1/24:1(15Z)) [M+H]+ | 972.7328077 | 401.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(60:11) [M+Na]+ | 975.7408 | 579.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | TAG(60:2) [M+NH4]+ | 988.9263934 | 723.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(16:1) [M+Chol-head-H2O+H]+ | 991.9197 | 621 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | Lactosylceramide (d18:1/24:1(15Z)) [M+Na]+ | 994.717011 | 401.4 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | CE(18:2) [M+Chol-head-H2O+H]+ | 1017.935682 | 624.6 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN002673 | 1_CE(22:1) iSTD [M+Chol-head-H2O+H]+ | 1076.016116 | 703.8 | Minutes | ST001636 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
